|
1
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Am Oncol. 22:2675–2686. 2011.
|
|
2
|
Dürst M, Gissmann L, Ikenberg H and zur
Hausen H: A papillomavirus DNA from a cervical carcinoma and its
prevalence in cancer biopsy samples from different geographic
regions. Proc Natl Acad Sci. 80:3812–3815. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
zurHausen H: Papillomaviruses causing
cancer: Evasion from host-cell control in early events in
carcinogenesis. J Natl Cancer Inst. 92:690–698. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Korzeniewski N, Spardy N, Duensing A and
Duensing S: Genomic instability and cancer: Lessons learned from
human papillomaviruses. Cancer Lett. 305:113–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Visnovsky J, Kudela E, Farkasova A,
Balharek T, Krkoska M and Danko J: Amplification of TERT and TERC
genes in cervical intraepithelial neoplasia and cervical cancer.
Neuro Endocrinol Lett. 35:518–522. 2014.PubMed/NCBI
|
|
6
|
McCredie MR, Sharples KJ, Paul C, Baranyia
J, Medley G, Jones RW and Skegg DC: Natural history of cervical
neoplasia and risk of invasive cancer in women with cervical
intraepithelial neoplasia 3: A retrospective cohort study. Lancet
Oncol. 9:425–434. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Boone JD, Erickson BK and Huh WK: New
insights into cervical cancer screening. J Gynecol Oncol.
23:282–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dunne EF and Markowitz LE: Genital human
papillomavirus infection. Clin Infect Dis. 43:624–629. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tjalma WA: The ideal cervical cancer
screening recommendation for Belgium, an industrialized country in
Europe. Eur J Gynaecol Oncol. 35:211–218. 2014.PubMed/NCBI
|
|
10
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D and Wright T Jr:
The 2001 Bethesda system: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bentley J, Bertrand M, Brydon L, Gagne H,
Hauck B, Mayrand MH, McFaul S, Power P, Schepansky A and
Straszak-Suri M: Colposcopic management of abnormal cervical
cytology and histology. J Obstet Gynaecol Can. 34:1188–1202. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayrand MH, Duarte-Franco E, Rodrigues I,
Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F and Franco EL:
Canadian Cervical Cancer Screening Trial Study Group: Human
papillomavirus DNA versus Papanicolaou screening tests for cervical
cancer. N Engl J Med. 357:1579–1588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Agramunt S, Checa MÁ, Gonzáles-Comadrán M,
Larrazabai F, Arbós A, Alameda F, Mancebo G and Carreras R:
High-grade squamous intraepithelial lesion could be managed
conservatively in women up to 25 years: Results from a
retrospective cohort study. J Low Genit Tract Dis. 17:459–462.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tindle RW: Immune evasion in human
papillomavirus-associated cervical cancer. Nat Rev Cancer. 2:59–65.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang A, Amagai M, Granger LG, Stanley JR
and Udey MC: Adhesion of epidermal Langerhans cells to
keratinocytes mediated by E-cadherin. Nature. 361:82–85. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hubert P, Caberg JH, Gilles C, Bousarghin
L, Franzen-Detrooz E, Boniver J and Delvenne P:
E-cadherin-dependent adhesion of dendritic and Langerhans cells to
keratinocytes is defective in cervical human
papillomavirus-associated (pre)neoplastic lesions. J Pathol.
206:346–355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oda H and Takeichi M: Evolution:
Structural and functional diversity of cadherin at the adherens
junction. J Cell Biol. 193:1137–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pećina-Slaus N: Tumor suppressor gene
E-cadherin and its role in normal and malignant cells. Cancer Cell
Int. 3:172003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sebova K, Zmetakova I, Bella V, Kajo K,
Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M,
Galbavy S and Fridrichova I: RASSF1A and CDH1 hypermethylation as
potential epimarkers in breast cancer. Cancer Biomark. 10:13–26.
2011–2012.
|
|
20
|
Wijnhoven BP, Dinjens WN and Pignatelli M:
E-cadherin-catenin cell-cell adhesion complex and human cancer. Br
J Surg. 87:992–1005. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wajed SA, Laird PW and DeMeester TR: DNA
methylation: An alternative pathway to cancer. Ann Surg. 234:10–20.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baylin SB and Herman JG: DNA
hypermethylation in tumorigenesis: Epigenetics joins genetics.
Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wentzensen N, Sherman ME, Schiffman M and
Wang SS: Utility of methylation markers in cervical cancer early
detection: Appraisal of the state-of-the-science. Gynecol Oncol.
112:293–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Narayan G, Arias-Pulido H, Koul S, Vargas
H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M and
Murty VV: Frequent promoter methylation of CDH1, DAPK, RARB, and
HIC1 genes in carcinoma of cervix uteri: Its relationship to
clinical outcome. Mol Cancer. 2:242003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Janusicova V, Mendelova A, Zubor P,
Kapustova I, Svecova I, Kudela E, Burjanivova T, Lasabova Z and
Danko J: mRNA expression in cervical specimens for determination of
severe dysplasia or worse in HPV-16/18-positive squamous lesions. J
Low Genit Tract Dis. 18:273–280. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
House MG, Guo M, Iacobuzio-Donahue C and
Herman JG: Molecular progression of promoter methylation in
intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
Carcinogenesis. 24:193–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leeb H and Pötscher BM: Model selection
and inference: Facts and fiction. Econometric Theory. 1:21–59.
2005.
|
|
28
|
Caldeira JR, Prando EC, Quevedo FC, Neto
FA, Rainho CA and Rogatto SR: CDH1 promoter hypermethylation and
E-cadherin protein expression in infiltrating breast cancer. BMC
Cancer. 6:482006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dhillon VS, Young AR, Husain SA and Aslam
M: Promoter hypermethylation of MGMT, CDH1, RAR-beta and SYK tumour
suppressor genes in granulosa cell tumours (GCTs) of ovarian
origin. Br J Cancer. 90:874–881. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Visnovsky J, Fiolka R, Kudela E, Slavik P,
Krkoska M, Lasabová Z and Danko J: Hypermethylation of selected
genes in endometrial carcinogenesis. Neuro Endocrinol Lett.
34:675–680. 2013.PubMed/NCBI
|
|
31
|
Abudukadeer A, Bakry R, Goebel G,
Mutz-Dehbalaie I, Widschendter A, Bonn GK and Fiegl H: Clinical
relevance of CDH1 and CDH13 DNA-methylation in serum of cervical
cancer patients. Int J Mol Sci. 13:8353–8363. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gustafson KS, Furth EE, Heitjan DF,
Fansler ZB and Clark DP: DNA methylation profiling of cervical
squamous intraepithelial lesions using liquid-based cytology
specimens: An approach that utilizes receiver-operating
characteristic analysis. Cancer. 102:259–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim JH, Choi YD, Lee JS, Lee JH, Nam JH
and Choi C: Assessment of DNA methylation for the detection of
cervical neoplasia in liquid-based cytology specimens. Gynecol
Oncol. 116:99–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McCormick TM, Canedo NH, Furtado YL,
Silveira FA, de Lima RJ, Rosman AD, Filho GL Almeida and Mda G
Carvalho: Association between human papillomavirus and Epstein-Barr
virus DNA and gene promoter methylation of RB1 and CDH1 in the
cervical lesions: A transversal study. Diagn Pathol. 10:592015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu Z and Taylor JA: Genome-wide
age-related DNA methylation changes in blood and other tissues
relate to histone modification, expression and cancer.
Carcinogenesis. 35:356–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung M and Pfeifer GP: Aging and DNA
methylation. BMC Biol. 13:72015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leonard SM, Wei W, Collins SI, Pereira M,
Divaf A, Constandinou-Williams C, Young LS, Roberts S and Woodman
CB: Oncogenic human papillomavirus imposes an instructive pattern
of DNA methylation changes which parallel the natural history of
cervical HPV infection in young women. Carcinogenesis.
33:1286–1293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: Unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
D'Costa ZJ, Jolly C, Androphy EJ, Mercer
A, Matthews CM and Hibma MH: Transcriptional repression of
E-cadherin by human papillomavirus type 16 E6. PLoS One.
7:e489542012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Flatley JE, McNeir K, Balasubramani L,
Tidy J, Stuart EL, Young TA and Powers HJ: Folate status and
aberrant DNA methylation are associated with HPV infection and
cervical pathogenesis. Cancer Epidemiol Biomarkers Prev.
18:2782–2789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Attaleb M, El hamadani W, Khyatti M,
Benbacer L, Benchekroun N, Benider A, Amrani M and El Mzibbri M:
Status of p16(INK4a) and E-cadherin gene promoter methylation in
Moroccan patients with cervical carcinoma. Oncol Res. 18:185–192.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kahn SL, Ronnett BM, Gravitt PE and
Gustafson KS: Quantitative methylation-specific PCR for the
detection of aberrant DNA methylation in liquid-based Pap tests.
Cancer. 114:57–64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tost J and Gut IG: DNA methylation
analysis by pyrosequencing. Nat Protoc. 2:2265–2275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Colella S, Shen L, Baggerly KA, Issa JP
and Krahe R: Sensitive and quantitative universal Pyrosequencing
methylation analysis of CpG sites. Biotechniques. 35:146–150.
2003.PubMed/NCBI
|
|
46
|
Siegel EM, Riggs BM, Delmas AL, Koch A,
Hakam A and Brown KD: Quantitative DNA methylation analysis of
candidate genes in cervical cancer. PLoS One. 10:e01224952015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
48
|
Branca M, Giorgi C, Ciotti M, Santini D,
Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba
P, et al: HPV-PathogenISS Study Group: Down-regulation of
E-cadherin is closely associated with progression of cervical
intraepithelial neoplasia (CIN), but not with high-risk human
papillomavisrus (HPV) or disease outcome in cervical cancer. Eur J
Gynaecol Oncol. 27:215–223. 2006.PubMed/NCBI
|
|
49
|
Strathdee G: Epigenetic versus genetic
alterations in the inactivation of E-cadherin. Semin Cancer Biol.
12:373–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Thomas M, Pim D and Banks L: The role of
the E6-p53 interaction in the molecular pathogenesis of HPV.
Oncogene. 18:7690–7700. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hirohashi S: Inactivation of the
E-cadherin-mediated cell adhesion system in human cancers. Am J
Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Liu YN, Lee WW, Wang CY, Chao TH, Chen Y
and Chen JH: Regulatory mechanisms controlling human E-cadherin
gene expression. Oncogene. 24:8277–8290. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kwon O, Jeong SJ, Kim SO, He L, Lee HG,
Jang KL, Osada H, Jung M, Kim BY and Ahn JS: Modulation of
E-cadherin expression by K-Ras; involvement of DNA
methyltransferase-3b. Carcinogenesis. 31:1194–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Syrjänen K, Kataja V, Yliskoski M, Chang
F, Syrjänen S and Saarikoski S: Natural history of cervical human
papillomavirus lesions does not substantiate the biologic relevance
of the Bethesda system. Obstet Gynecol. 79:675–682. 1992.PubMed/NCBI
|
